Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status.

Rajagopalan H, Bardelli A, Lengauer C, Kinzler KW, Vogelstein B, Velculescu VE.

Nature. 2002 Aug 29;418(6901):934.

PMID:
12198537
2.

K-ras and B-raf gene mutations are not associated with gastrin- and CCK2-receptor mRNA expression in human colorectal tumour tissues.

Monstein HJ, Fransén K, Dimberg J, Söderkvist P.

Eur J Clin Invest. 2004 Feb;34(2):100-6.

PMID:
14764072
3.

RAS/RAF mutation and defective DNA mismatch repair in endometrial cancers.

Mutch DG, Powell MA, Mallon MA, Goodfellow PJ.

Am J Obstet Gynecol. 2004 Apr;190(4):935-42.

PMID:
15118616
4.

Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas.

Fransén K, Klintenäs M, Osterström A, Dimberg J, Monstein HJ, Söderkvist P.

Carcinogenesis. 2004 Apr;25(4):527-33.

5.

Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma.

Singer G, Oldt R 3rd, Cohen Y, Wang BG, Sidransky D, Kurman RJ, Shih IeM.

J Natl Cancer Inst. 2003 Mar 19;95(6):484-6.

6.

Ischemia-induced K-ras mutations in human colorectal cancer cells: role of microenvironmental regulation of MSH2 expression.

Shahrzad S, Quayle L, Stone C, Plumb C, Shirasawa S, Rak JW, Coomber BL.

Cancer Res. 2005 Sep 15;65(18):8134-41.

7.

BRAF mutations characterize colon but not gastric cancer with mismatch repair deficiency.

Oliveira C, Pinto M, Duval A, Brennetot C, Domingo E, Espín E, Armengol M, Yamamoto H, Hamelin R, Seruca R, Schwartz S Jr.

Oncogene. 2003 Dec 11;22(57):9192-6.

PMID:
14668801
8.

Activated BRAF targets proximal colon tumors with mismatch repair deficiency and MLH1 inactivation.

Domingo E, Espín E, Armengol M, Oliveira C, Pinto M, Duval A, Brennetot C, Seruca R, Hamelin R, Yamamoto H, Schwartz S Jr.

Genes Chromosomes Cancer. 2004 Feb;39(2):138-42.

PMID:
14695993
9.

Mutational analysis of BRAF and K-ras in gastric cancers: absence of BRAF mutations in gastric cancers.

Kim IJ, Park JH, Kang HC, Shin Y, Park HW, Park HR, Ku JL, Lim SB, Park JG.

Hum Genet. 2003 Dec;114(1):118-20.

PMID:
14513361
10.

Mutational activation of the RAS-RAF-MAPK and the Wnt pathway in small intestinal adenocarcinomas.

Bläker H, Helmchen B, Bönisch A, Aulmann S, Penzel R, Otto HF, Rieker RJ.

Scand J Gastroenterol. 2004 Aug;39(8):748-53.

PMID:
15513360
11.
12.
13.

Both BRAF and KRAS mutations are rare in colorectal carcinomas from patients with hereditary nonpolyposis colorectal cancer.

Miyaki M, Iijima T, Yamaguchi T, Kadofuku T, Funata N, Mori T.

Cancer Lett. 2004 Jul 28;211(1):105-9.

PMID:
15194222
14.

MutYH (MYH) and colorectal cancer.

Sampson JR, Jones S, Dolwani S, Cheadle JP.

Biochem Soc Trans. 2005 Aug;33(Pt 4):679-83. Review.

PMID:
16042573
15.

Low somatic K-ras mutation frequency in colorectal cancer diagnosed under the age of 45 years.

Alsop K, Mead L, Smith LD, Royce SG, Tesoriero AA, Young JP, Haydon A, Grubb G, Giles GG, Jenkins MA, Hopper JL, Southey MC.

Eur J Cancer. 2006 Jul;42(10):1357-61.

PMID:
16765042
16.

Oncogenic pathway of sporadic colorectal cancer with novel germline missense mutations in the hMSH2 gene.

Yamada K, Zhong X, Kanazawa S, Koike J, Tsujita K, Hemmi H.

Oncol Rep. 2003 Jul-Aug;10(4):859-66.

PMID:
12792735
17.

In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours.

Sieben NL, Macropoulos P, Roemen GM, Kolkman-Uljee SM, Jan Fleuren G, Houmadi R, Diss T, Warren B, Al Adnani M, De Goeij AP, Krausz T, Flanagan AM.

J Pathol. 2004 Mar;202(3):336-40.

PMID:
14991899
18.

Lack of BRAF mutation in primary uveal melanoma.

Cohen Y, Goldenberg-Cohen N, Parrella P, Chowers I, Merbs SL, Pe'er J, Sidransky D.

Invest Ophthalmol Vis Sci. 2003 Jul;44(7):2876-8.

PMID:
12824225
19.
20.

Genetic and epigenetic alterations of Ras signalling pathway in colorectal neoplasia: analysis based on tumour clinicopathological features.

Harada K, Hiraoka S, Kato J, Horii J, Fujita H, Sakaguchi K, Shiratori Y.

Br J Cancer. 2007 Nov 19;97(10):1425-31.

Items per page

Supplemental Content

Support Center